livehealth.store

Payless Compounders recalls

Payless Compounders has 1 recall on record with the FDA and USDA, the earliest in 2026 and the latest reported on 22 Apr 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is sterility.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 22 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 1Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why payless compounders is recalled

Sterility1100%

Product types

Diabetes Medication1100%

By year

20261100%

Ongoing payless compounders recalls

1 active

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled	Payless Compounders	Sterility	OR

All payless compounders recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Apr 2026Drug	CLASS II	Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled	Payless Compounders	Sterility	OR

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.